HLA class I, KIR polymorphisms and KIR-HLA interactions in epithelial ovarian cancer: associations with susceptibility, platinum resistance and survival

Background Natural killer (NK) cell activity is regulated by killer-cell immunoglobulin-like receptors (KIR) and their HLA class I ligands. Whether specific KIR/HLA genotypes influence susceptibility to, or prognosis of, epithelial ovarian cancer (EOC) remains poorly defined. Methods We genotyped 16 KIR genes and HLA-A, -B and -C alleles in 64 women with EOC and 54 age-comparable cancer-free controls. Within the EOC cohort, we compared KIR/HLA distribution between platinum-sensitive (n=53) and platinum-resistant (n=11) patients, and evaluated progression-free survival (PFS) and overall survival (OS) by Kaplan-Meier and multivariable Cox regression adjusted for BRCA1/2 status, homologous recombination deficiency (HRD), FIGO stage and ECOG status. Given the number of comparisons performed, findings are reported as exploratory and hypothesis-generating. Results HLA-A*11:01 was overrepresented in cases (28.1% vs 11.1%; OR = 3.13), while HLA-B*38:01 was underrepresented (3.1% vs 14.8%; OR = 0.19). No individual KIR gene or canonical KIR-HLA pair differed between cases and controls. Within the EOC cohort, HLA-A*29:02 and HLA-B*37:01 were more frequent among platinum-resistant patients; in a backward-elimination multivariable Cox analysis, only HLA-B*37:01 and ECOG ≥2 remained independent predictors of shorter PFS and OS, with BRCA1/2 mutation additionally significant for PFS. Co-presence of the receptor KIR2DS1 with HLA-C2 was associated with a higher crude relapse rate (90.0% vs 61.4%; p=0.022), not confirmed by a time-to-event analysis (p=0.52). Conclusion HLA-A*11:01 and HLA-B*38:01 were associated with EOC susceptibility, and HLA-A*29:02 and HLA-B*37:01 were associated with platinum resistance, but only the rare HLA-B*37:01 remained an independent predictor of survival after adjustment; these exploratory findings warrant validation in larger, independent cohorts.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-19
DOI
https://doi.org/10.3389/fimmu.2026.1971500
Primary Topic
Immune Cell Function and Interaction
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

HLA class I, KIR polymorphisms and KIR-HLA interactions in epithelial ovarian cancer: associations with susceptibility, platinum resistance and survival

Luis Perez-Bartivas, Rafael González Fernández, Bárbara Manzanares Martin, Maria Jesus Rubio Pérez et al.
Frontiers in Immunology
Immune Cell Function and Interaction
article

HLA class I, KIR polymorphisms and KIR-HLA interactions in epithelial ovarian cancer: associations with susceptibility, platinum resistance and survival

Luis Perez-Bartivas, Rafael González Fernández, Bárbara Manzanares Martin, Maria Jesus Rubio Pérez, Beatriz Teso Martín, Enrique Aranda Aguilar, Icíar De La Fuente DomÃnguez, Juan de la Haba Rodríguez, David Ponferrada Álvarez, Javier Caballero Villarraso
article en

Abstract

Background Natural killer (NK) cell activity is regulated by killer-cell immunoglobulin-like receptors (KIR) and their HLA class I ligands. Whether specific KIR/HLA genotypes influence susceptibility to, or prognosis of, epithelial ovarian cancer (EOC) remains poorly defined. Methods We genotyped 16 KIR genes and HLA-A, -B and -C alleles in 64 women with EOC and 54 age-comparable cancer-free controls. Within the EOC cohort, we compared KIR/HLA distribution between platinum-sensitive (n=53) and platinum-resistant (n=11) patients, and evaluated progression-free survival (PFS) and overall survival (OS) by Kaplan-Meier and multivariable Cox regression adjusted for BRCA1/2 status, homologous recombination deficiency (HRD), FIGO stage and ECOG status. Given the number of comparisons performed, findings are reported as exploratory and hypothesis-generating. Results HLA-A*11:01 was overrepresented in cases (28.1% vs 11.1%; OR = 3.13), while HLA-B*38:01 was underrepresented (3.1% vs 14.8%; OR = 0.19). No individual KIR gene or canonical KIR-HLA pair differed between cases and controls. Within the EOC cohort, HLA-A*29:02 and HLA-B*37:01 were more frequent among platinum-resistant patients; in a backward-elimination multivariable Cox analysis, only HLA-B*37:01 and ECOG ≥2 remained independent predictors of shorter PFS and OS, with BRCA1/2 mutation additionally significant for PFS. Co-presence of the receptor KIR2DS1 with HLA-C2 was associated with a higher crude relapse rate (90.0% vs 61.4%; p=0.022), not confirmed by a time-to-event analysis (p=0.52). Conclusion HLA-A*11:01 and HLA-B*38:01 were associated with EOC susceptibility, and HLA-A*29:02 and HLA-B*37:01 were associated with platinum resistance, but only the rare HLA-B*37:01 remained an independent predictor of survival after adjustment; these exploratory findings warrant validation in larger, independent cohorts.

Frontiers in ImmunologyVol. 17
Instituto Maimónides de Investigación Biomédica de Córdoba (ES), Hospital Universitario Reina Sofía (ES), University of Córdoba (ES)
Immune Cell Function and Interaction
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon